Industry Research Reports

Home > Reports > Chemical & Material > Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Chemical & Material

Published Date: 2026-06-16

Pages: 138 Pages

Report ld: 6784603

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Roxithromycin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Roxithromycin API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report provides a comprehensive view of the global market for Roxithromycin API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Roxithromycin API market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Roxithromycin API.

MARKET SEGMENTATION

By Company

Otto Brandes
Beijing Mesochem Technology
Century Pharmaceuticals
Octavius Pharma Pvt. Ltd
HEC Pharm
Kopran
Alembic Pharmaceuticals Limited
Envee Drugs
Zhejiang Zhenyuan Pharmaceutical
Huangshi Shixing Pharmaceutical
Hanways Chempharm Co., Limited

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Above 98 %
Above 99 %

Segment by Application

Tablets
Capsules
Granules
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Roxithromycin API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Roxithromycin API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Roxithromycin API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Roxithromycin API Product Introduction

1.2 Global Roxithromycin API Market Size Forecast

1.2.1 Global Roxithromycin API Sales Value (2021–2032)

1.2.2 Global Roxithromycin API Sales Volume (2021–2032)

1.2.3 Global Roxithromycin API Sales Price (2021–2032)

1.3 Roxithromycin API Market Trends & Drivers

1.3.1 Roxithromycin API Industry Trends

1.3.2 Roxithromycin API Market Drivers & Opportunities

1.3.3 Roxithromycin API Market Challenges

1.3.4 Roxithromycin API Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Roxithromycin API Players Revenue Ranking (2025)

2.2 Global Roxithromycin API Revenue by Company (2021–2026)

2.3 Global Roxithromycin API Sales Volume Ranking of Players (2025)

2.4 Global Roxithromycin API Sales Volume by Company (2021–2026)

2.5 Global Roxithromycin API Average Price by Company (2021–2026)

2.6 Key Manufacturers Roxithromycin API Manufacturing Base and Headquarters

2.7 Key Manufacturers Roxithromycin API Product Offerings

2.8 Key Manufacturers Start of Mass Production of Roxithromycin API

2.9 Roxithromycin API Market Competitive Analysis

2.9.1 Roxithromycin API Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Roxithromycin API Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Roxithromycin API revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Roxithromycin API Market Classification

3.1 Introduction by Type

3.1.1 Above 98 %

3.1.2 Above 99 %

3.1.3 Global Roxithromycin API Sales Value by Type

3.1.3.1 Global Roxithromycin API Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Roxithromycin API Sales Value, by Type (2021–2032)

3.1.3.3 Global Roxithromycin API Sales Value, by Type (%), 2021–2032

3.1.4 Global Roxithromycin API Sales Volume by Type

3.1.4.1 Global Roxithromycin API Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Roxithromycin API Sales Volume, by Type (2021–2032)

3.1.4.3 Global Roxithromycin API Sales Volume, by Type (%), 2021–2032

3.1.5 Global Roxithromycin API Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Tablets

4.1.2 Capsules

4.1.3 Granules

4.1.4 Others

4.2 Global Roxithromycin API Sales Value by Application

4.2.1 Global Roxithromycin API Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Roxithromycin API Sales Value, by Application (2021–2032)

4.2.3 Global Roxithromycin API Sales Value, by Application (%), 2021–2032

4.3 Global Roxithromycin API Sales Volume by Application

4.3.1 Global Roxithromycin API Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Roxithromycin API Sales Volume, by Application (2021–2032)

4.3.3 Global Roxithromycin API Sales Volume, by Application (%), 2021–2032

4.4 Global Roxithromycin API Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Roxithromycin API Sales Value by Region

5.1.1 Global Roxithromycin API Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Roxithromycin API Sales Value by Region (2021–2026)

5.1.3 Global Roxithromycin API Sales Value by Region (2027–2032)

5.1.4 Global Roxithromycin API Sales Value by Region (%), 2021–2032

5.2 Global Roxithromycin API Sales Volume by Region

5.2.1 Global Roxithromycin API Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Roxithromycin API Sales Volume by Region (2021–2026)

5.2.3 Global Roxithromycin API Sales Volume by Region (2027–2032)

5.2.4 Global Roxithromycin API Sales Volume by Region (%), 2021–2032

5.3 Global Roxithromycin API Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Roxithromycin API Sales Value, 2021–2032

5.4.2 North America Roxithromycin API Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Roxithromycin API Sales Value, 2021–2032

5.5.2 Europe Roxithromycin API Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Roxithromycin API Sales Value, 2021–2032

5.6.2 Asia Pacific Roxithromycin API Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Roxithromycin API Sales Value, 2021–2032

5.7.2 South America Roxithromycin API Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Roxithromycin API Sales Value, 2021–2032

5.8.2 Middle East & Africa Roxithromycin API Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Roxithromycin API Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Roxithromycin API Sales Value and Sales Volume

6.2.1 Key Countries/Regions Roxithromycin API Sales Value, 2021–2032

6.2.2 Key Countries/Regions Roxithromycin API Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Roxithromycin API Sales Value, 2021–2032

6.3.2 United States Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Roxithromycin API Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Roxithromycin API Sales Value, 2021–2032

6.4.2 Europe Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Roxithromycin API Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Roxithromycin API Sales Value, 2021–2032

6.5.2 China Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.5.3 China Roxithromycin API Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Roxithromycin API Sales Value, 2021–2032

6.6.2 Japan Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Roxithromycin API Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Roxithromycin API Sales Value, 2021–2032

6.7.2 South Korea Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Roxithromycin API Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Roxithromycin API Sales Value, 2021–2032

6.8.2 Southeast Asia Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Roxithromycin API Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Roxithromycin API Sales Value, 2021–2032

6.9.2 India Roxithromycin API Sales Value by Type (%), 2025 vs 2032

6.9.3 India Roxithromycin API Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Otto Brandes

7.1.1 Otto Brandes Company Information

7.1.2 Otto Brandes Introduction and Business Overview

7.1.3 Otto Brandes Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Otto Brandes Roxithromycin API Product Offerings

7.1.5 Otto Brandes Recent Developments

7.2 Beijing Mesochem Technology

7.2.1 Beijing Mesochem Technology Company Information

7.2.2 Beijing Mesochem Technology Introduction and Business Overview

7.2.3 Beijing Mesochem Technology Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Beijing Mesochem Technology Roxithromycin API Product Offerings

7.2.5 Beijing Mesochem Technology Recent Developments

7.3 Century Pharmaceuticals

7.3.1 Century Pharmaceuticals Company Information

7.3.2 Century Pharmaceuticals Introduction and Business Overview

7.3.3 Century Pharmaceuticals Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Century Pharmaceuticals Roxithromycin API Product Offerings

7.3.5 Century Pharmaceuticals Recent Developments

7.4 Octavius Pharma Pvt. Ltd

7.4.1 Octavius Pharma Pvt. Ltd Company Information

7.4.2 Octavius Pharma Pvt. Ltd Introduction and Business Overview

7.4.3 Octavius Pharma Pvt. Ltd Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Octavius Pharma Pvt. Ltd Roxithromycin API Product Offerings

7.4.5 Octavius Pharma Pvt. Ltd Recent Developments

7.5 HEC Pharm

7.5.1 HEC Pharm Company Information

7.5.2 HEC Pharm Introduction and Business Overview

7.5.3 HEC Pharm Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.5.4 HEC Pharm Roxithromycin API Product Offerings

7.5.5 HEC Pharm Recent Developments

7.6 Kopran

7.6.1 Kopran Company Information

7.6.2 Kopran Introduction and Business Overview

7.6.3 Kopran Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.6.4 Kopran Roxithromycin API Product Offerings

7.6.5 Kopran Recent Developments

7.7 Alembic Pharmaceuticals Limited

7.7.1 Alembic Pharmaceuticals Limited Company Information

7.7.2 Alembic Pharmaceuticals Limited Introduction and Business Overview

7.7.3 Alembic Pharmaceuticals Limited Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.7.4 Alembic Pharmaceuticals Limited Roxithromycin API Product Offerings

7.7.5 Alembic Pharmaceuticals Limited Recent Developments

7.8 Envee Drugs

7.8.1 Envee Drugs Company Information

7.8.2 Envee Drugs Introduction and Business Overview

7.8.3 Envee Drugs Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.8.4 Envee Drugs Roxithromycin API Product Offerings

7.8.5 Envee Drugs Recent Developments

7.9 Zhejiang Zhenyuan Pharmaceutical

7.9.1 Zhejiang Zhenyuan Pharmaceutical Company Information

7.9.2 Zhejiang Zhenyuan Pharmaceutical Introduction and Business Overview

7.9.3 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.9.4 Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Offerings

7.9.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments

7.10 Huangshi Shixing Pharmaceutical

7.10.1 Huangshi Shixing Pharmaceutical Company Information

7.10.2 Huangshi Shixing Pharmaceutical Introduction and Business Overview

7.10.3 Huangshi Shixing Pharmaceutical Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.10.4 Huangshi Shixing Pharmaceutical Roxithromycin API Product Offerings

7.10.5 Huangshi Shixing Pharmaceutical Recent Developments

7.11 Hanways Chempharm Co., Limited

7.11.1 Hanways Chempharm Co., Limited Company Information

7.11.2 Hanways Chempharm Co., Limited Introduction and Business Overview

7.11.3 Hanways Chempharm Co., Limited Roxithromycin API Sales, Revenue, Price and Gross Margin (2021–2026)

7.11.4 Hanways Chempharm Co., Limited Roxithromycin API Product Offerings

7.11.5 Hanways Chempharm Co., Limited Recent Developments

8 Industry Chain Analysis

8.1 Roxithromycin API Industrial Chain

8.2 Roxithromycin API Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Roxithromycin API Sales Model

8.5.2 Sales Channels

8.5.3 Roxithromycin API Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Roxithromycin API Market Trends

Table 2. Roxithromycin API Market Drivers & Opportunities

Table 3. Roxithromycin API Market Challenges

Table 4. Roxithromycin API Market Restraints

Table 5. Global Roxithromycin API Revenue by Company (US$ Million), 2021–2026

Table 6. Global Roxithromycin API Revenue Market Share by Company (2021–2026)

Table 7. Global Roxithromycin API Sales Volume by Company (Kg), 2021–2026

Table 8. Global Roxithromycin API Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Roxithromycin API Price by Company (US$/Kg), 2021–2026

Table 10. Key Manufacturers Roxithromycin API Manufacturing Base and Headquarters

Table 11. Key Manufacturers Roxithromycin API Product Type

Table 12. Key Manufacturers Start of Mass Production of Roxithromycin API

Table 13. Global Roxithromycin API Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Roxithromycin API revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Roxithromycin API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Roxithromycin API Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Roxithromycin API Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Roxithromycin API Sales Market Share in Value by Type (2021–2026)

Table 20. Global Roxithromycin API Sales Market Share in Value by Type (2027–2032)

Table 21. Global Roxithromycin API Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Roxithromycin API Sales Volume by Type (Kg), 2021–2026

Table 23. Global Roxithromycin API Sales Volume by Type (Kg), 2027–2032

Table 24. Global Roxithromycin API Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Roxithromycin API Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Roxithromycin API Price by Type (US$/Kg), 2021–2026

Table 27. Global Roxithromycin API Price by Type (US$/Kg), 2027–2032

Table 28. Global Roxithromycin API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Roxithromycin API Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Roxithromycin API Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Roxithromycin API Sales Market Share in Value by Application (2021–2026)

Table 32. Global Roxithromycin API Sales Market Share in Value by Application (2027–2032)

Table 33. Global Roxithromycin API Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)

Table 34. Global Roxithromycin API Sales Volume by Application (Kg), 2021–2026

Table 35. Global Roxithromycin API Sales Volume by Application (Kg), 2027–2032

Table 36. Global Roxithromycin API Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Roxithromycin API Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Roxithromycin API Price by Application (US$/Kg), 2021–2026

Table 39. Global Roxithromycin API Price by Application (US$/Kg), 2027–2032

Table 40. Global Roxithromycin API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Roxithromycin API Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Roxithromycin API Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Roxithromycin API Sales Value by Region (%), 2021–2026

Table 44. Global Roxithromycin API Sales Value by Region (%), 2027–2032

Table 45. Global Roxithromycin API Sales Volume by Region (Kg): 2021 vs 2025 vs 2032

Table 46. Global Roxithromycin API Sales Volume by Region (Kg), 2021–2026

Table 47. Global Roxithromycin API Sales Volume by Region (Kg), 2027–2032

Table 48. Global Roxithromycin API Sales Volume by Region (%), 2021–2026

Table 49. Global Roxithromycin API Sales Volume by Region (%), 2027–2032

Table 50. Global Roxithromycin API Average Price by Region (US$/Kg), 2021–2026

Table 51. Global Roxithromycin API Average Price by Region (US$/Kg), 2027–2032

Table 52. Key Countries/Regions Roxithromycin API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Roxithromycin API Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Roxithromycin API Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Roxithromycin API Sales Volume, (Kg), 2021–2026

Table 56. Key Countries/Regions Roxithromycin API Sales Volume, (Kg), 2027–2032

Table 57. Otto Brandes Company Information

Table 58. Otto Brandes Introduction and Business Overview

Table 59. Otto Brandes Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 60. Otto Brandes Roxithromycin API Product Offerings

Table 61. Otto Brandes Recent Developments

Table 62. Beijing Mesochem Technology Company Information

Table 63. Beijing Mesochem Technology Introduction and Business Overview

Table 64. Beijing Mesochem Technology Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 65. Beijing Mesochem Technology Roxithromycin API Product Offerings

Table 66. Beijing Mesochem Technology Recent Developments

Table 67. Century Pharmaceuticals Company Information

Table 68. Century Pharmaceuticals Introduction and Business Overview

Table 69. Century Pharmaceuticals Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 70. Century Pharmaceuticals Roxithromycin API Product Offerings

Table 71. Century Pharmaceuticals Recent Developments

Table 72. Octavius Pharma Pvt. Ltd Company Information

Table 73. Octavius Pharma Pvt. Ltd Introduction and Business Overview

Table 74. Octavius Pharma Pvt. Ltd Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 75. Octavius Pharma Pvt. Ltd Roxithromycin API Product Offerings

Table 76. Octavius Pharma Pvt. Ltd Recent Developments

Table 77. HEC Pharm Company Information

Table 78. HEC Pharm Introduction and Business Overview

Table 79. HEC Pharm Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 80. HEC Pharm Roxithromycin API Product Offerings

Table 81. HEC Pharm Recent Developments

Table 82. Kopran Company Information

Table 83. Kopran Introduction and Business Overview

Table 84. Kopran Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 85. Kopran Roxithromycin API Product Offerings

Table 86. Kopran Recent Developments

Table 87. Alembic Pharmaceuticals Limited Company Information

Table 88. Alembic Pharmaceuticals Limited Introduction and Business Overview

Table 89. Alembic Pharmaceuticals Limited Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 90. Alembic Pharmaceuticals Limited Roxithromycin API Product Offerings

Table 91. Alembic Pharmaceuticals Limited Recent Developments

Table 92. Envee Drugs Company Information

Table 93. Envee Drugs Introduction and Business Overview

Table 94. Envee Drugs Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 95. Envee Drugs Roxithromycin API Product Offerings

Table 96. Envee Drugs Recent Developments

Table 97. Zhejiang Zhenyuan Pharmaceutical Company Information

Table 98. Zhejiang Zhenyuan Pharmaceutical Introduction and Business Overview

Table 99. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 100. Zhejiang Zhenyuan Pharmaceutical Roxithromycin API Product Offerings

Table 101. Zhejiang Zhenyuan Pharmaceutical Recent Developments

Table 102. Huangshi Shixing Pharmaceutical Company Information

Table 103. Huangshi Shixing Pharmaceutical Introduction and Business Overview

Table 104. Huangshi Shixing Pharmaceutical Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 105. Huangshi Shixing Pharmaceutical Roxithromycin API Product Offerings

Table 106. Huangshi Shixing Pharmaceutical Recent Developments

Table 107. Hanways Chempharm Co., Limited Company Information

Table 108. Hanways Chempharm Co., Limited Introduction and Business Overview

Table 109. Hanways Chempharm Co., Limited Roxithromycin API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021–2026)

Table 110. Hanways Chempharm Co., Limited Roxithromycin API Product Offerings

Table 111. Hanways Chempharm Co., Limited Recent Developments

Table 112. Key Raw Materials Lists

Table 113. Key Suppliers of Raw Materials Lists

Table 114. Roxithromycin API Downstream Customers

Table 115. Roxithromycin API Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Roxithromycin API Product Picture

Figure 2. Global Roxithromycin API Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 4. Global Roxithromycin API Sales Volume (Kg), 2021–2032

Figure 5. Global Roxithromycin API Sales Price (US$/Kg), 2021–2032

Figure 6. Roxithromycin API Report Years Considered

Figure 7. Global Roxithromycin API Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Roxithromycin API Sales Volume Ranking of Players (Kg), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Roxithromycin API Revenue in 2025

Figure 10. Roxithromycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. Above 98 % Picture

Figure 12. Above 99 % Picture

Figure 13. Global Roxithromycin API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Roxithromycin API Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Roxithromycin API Sales Volume by Type (Kg), 2021 vs 2025 vs 2032

Figure 16. Global Roxithromycin API Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Roxithromycin API Price by Type (US$/Kg), 2021–2032

Figure 18. Product Picture of Tablets

Figure 19. Product Picture of Capsules

Figure 20. Product Picture of Granules

Figure 21. Product Picture of Others

Figure 22. Global Roxithromycin API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Roxithromycin API Sales Value Market Share by Application, 2025 & 2032

Figure 24. Global Roxithromycin API Sales Volume by Application (Kg), 2021 vs 2025 vs 2032

Figure 25. Global Roxithromycin API Sales Volume Market Share by Application, 2025 & 2032

Figure 26. Global Roxithromycin API Price by Application (US$/Kg), 2021–2032

Figure 27. North America Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 28. North America Roxithromycin API Sales Value by Country (%), 2025 vs 2032

Figure 29. Europe Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 30. Europe Roxithromycin API Sales Value by Country (%), 2025 vs 2032

Figure 31. Asia Pacific Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 32. Asia Pacific Roxithromycin API Sales Value by Region (%), 2025 vs 2032

Figure 33. South America Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 34. South America Roxithromycin API Sales Value by Country (%), 2025 vs 2032

Figure 35. Middle East & Africa Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 36. Middle East & Africa Roxithromycin API Sales Value by Country (%), 2025 vs 2032

Figure 37. Key Countries/Regions Roxithromycin API Sales Value (%), 2021–2032

Figure 38. Key Countries/Regions Roxithromycin API Sales Volume (%), 2021–2032

Figure 39. United States Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 40. United States Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 41. United States Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 42. Europe Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 43. Europe Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 44. Europe Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 45. China Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 46. China Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 47. China Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 48. Japan Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 49. Japan Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 50. Japan Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 51. South Korea Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 52. South Korea Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 53. South Korea Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 54. Southeast Asia Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 55. Southeast Asia Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 56. Southeast Asia Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 57. India Roxithromycin API Sales Value (US$ Million), 2021–2032

Figure 58. India Roxithromycin API Sales Value by Type (%), 2025 vs 2032

Figure 59. India Roxithromycin API Sales Value by Application (%), 2025 vs 2032

Figure 60. Roxithromycin API Industrial Chain

Figure 61. Roxithromycin API Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Roxithromycin API market? zhanKai

The top companies in the global Roxithromycin API market are Otto Brandes、Beijing Mesochem Technology、Century Pharmaceuticals.

Related Reports

Global Roxithromycin API Market Research Report 2026
The global Roxithromycin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 141
USD 2900.00
(Single User License)
Global Roxithromycin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roxithromycin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 99
USD 4250.00
(Single User License)
Global Roxithromycin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roxithromycin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 153
USD 4900.00
(Single User License)
Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roxithromycin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 118
USD 3950.00
(Single User License)
Global Roxithromycin API Market Research Report 2025
The global market for Roxithromycin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 96
USD 2900.00
(Single User License)
Global Roxithromycin API Market Research Report 2024
Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
Published Date: 2024-02-07
Pages: 104
USD 2900.00
(Single User License)

Global Roxithromycin API Market Research Report 2026
The global Roxithromycin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 141
USD 2900.00 (Single User License)
Global Roxithromycin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Roxithromycin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 99
USD 4250.00 (Single User License)
Global Roxithromycin API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Roxithromycin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 153
USD 4900.00 (Single User License)
Roxithromycin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Roxithromycin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 118
USD 3950.00 (Single User License)
Global Roxithromycin API Market Research Report 2025
The global market for Roxithromycin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 96
USD 2900.00 (Single User License)
Global Roxithromycin API Market Research Report 2024
Roxithromycin(CAS：80214-83-1) is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections.
Published: 2024-02-07
Pages: 104
USD 2900.00 (Single User License)